American Association of Clinical Endocrinology clinical practice guideline for the diagnosis and management of nonalcoholic fatty liver disease in primary care and …
K Cusi, S Isaacs, D Barb, R Basu, S Caprio… - Endocrine Practice, 2022 - Elsevier
Objective To provide evidence-based recommendations regarding the diagnosis and
management of nonalcoholic fatty liver disease (NAFLD) and nonalcoholic steatohepatitis …
management of nonalcoholic fatty liver disease (NAFLD) and nonalcoholic steatohepatitis …
Non-invasive methods for imaging hepatic steatosis and their clinical importance in NAFLD
Hepatic steatosis is a key histological feature of nonalcoholic fatty liver disease (NAFLD).
The non-invasive quantification of liver fat is now possible due to advances in imaging …
The non-invasive quantification of liver fat is now possible due to advances in imaging …
EASL Clinical Practice Guidelines on non-invasive tests for evaluation of liver disease severity and prognosis–2021 update
Non-invasive tests are increasingly being used to improve the diagnosis and
prognostication of chronic liver diseases across aetiologies. Herein, we provide the latest …
prognostication of chronic liver diseases across aetiologies. Herein, we provide the latest …
[HTML][HTML] Non-alcoholic fatty liver disease: A patient guideline
This patient guideline is intended for all patients at risk of or living with non-alcoholic fatty
liver disease (NAFLD). NAFLD is the most frequent chronic liver disease worldwide and …
liver disease (NAFLD). NAFLD is the most frequent chronic liver disease worldwide and …
Accuracy of controlled attenuation parameter (CAP) and liver stiffness measurement (LSM) for assessing steatosis and fibrosis in non-alcoholic fatty liver disease: A …
Y Cao, L Xiang, F Qi, Y Zhang, Y Chen, X Zhou - EClinicalMedicine, 2022 - thelancet.com
Background Non-alcoholic fatty liver disease (NAFLD) is a common chronic liver disease,
and among the non-invasive tests, controlled attenuation parameter (CAP) and liver stiffness …
and among the non-invasive tests, controlled attenuation parameter (CAP) and liver stiffness …
US attenuation for liver fat quantification: an AIUM-RSNA QIBA pulse-echo quantitative ultrasound initiative
Nonalcoholic fatty liver disease (NAFLD) is the most common chronic liver disease
worldwide, with an estimated prevalence of up to 30% in the general population and higher …
worldwide, with an estimated prevalence of up to 30% in the general population and higher …
Noninvasive assessment of liver fibrosis in NAFLD
Nonalcoholic fatty liver disease (NAFLD) has emerged as a leading cause of liver-related
morbidity and mortality worldwide, afflicting approximately a billion individuals. NAFLD is a …
morbidity and mortality worldwide, afflicting approximately a billion individuals. NAFLD is a …
Advances in the diagnosis and treatment of non-alcoholic fatty liver disease
X Yin, X Guo, Z Liu, J Wang - International Journal of Molecular Sciences, 2023 - mdpi.com
Non-alcoholic fatty liver disease (NAFLD) is the most prevalent chronic liver disease that
affects approximately one-quarter of the global adult population, posing a significant threat …
affects approximately one-quarter of the global adult population, posing a significant threat …
Quantification of liver fat content with ultrasound: a WFUMB position paper
G Ferraioli, A Berzigotti, RG Barr, BI Choi… - Ultrasound in medicine …, 2021 - Elsevier
New ultrasound methods that can be used to quantitatively assess liver fat content have
recently been developed. These quantitative ultrasound (QUS) methods are based on the …
recently been developed. These quantitative ultrasound (QUS) methods are based on the …
A multisociety Delphi consensus statement on new fatty liver disease nomenclature
The principal limitations of the terms NAFLD and NASH are the reliance on exclusionary
confounder terms and the use of potentially stigmatising language. This study set out to …
confounder terms and the use of potentially stigmatising language. This study set out to …